Status:
COMPLETED
An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Infections
Pelvic Infections
Eligibility:
All Genders
3-17 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the effect of an approved medication for adults for an investigational use in pediatric patients 3 months to 17 years for the treatment of complicated intra-a...
Detailed Description
The duration of treatment is 18 months.
Eligibility Criteria
Inclusion
- Patients aged 3 months to 17 years with intra-abdominal infection or acute pelvic infection
Exclusion
- Immune problems
- Kidney problems
Key Trial Info
Start Date :
March 1 2002
Trial Type :
INTERVENTIONAL
End Date :
January 1 2004
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00092170
Start Date
March 1 2002
End Date
January 1 2004
Last Update
February 17 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.